FR3067938B1 - USE OF A COSMETIC AND / OR DERMATOLOGICAL COMPOSITION AGAINST THE EFFECTS INDUCED BY BLUE LIGHT - Google Patents

USE OF A COSMETIC AND / OR DERMATOLOGICAL COMPOSITION AGAINST THE EFFECTS INDUCED BY BLUE LIGHT Download PDF

Info

Publication number
FR3067938B1
FR3067938B1 FR1770682A FR1770682A FR3067938B1 FR 3067938 B1 FR3067938 B1 FR 3067938B1 FR 1770682 A FR1770682 A FR 1770682A FR 1770682 A FR1770682 A FR 1770682A FR 3067938 B1 FR3067938 B1 FR 3067938B1
Authority
FR
France
Prior art keywords
cosmetic
blue light
effects induced
dermatological composition
composition against
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1770682A
Other languages
French (fr)
Other versions
FR3067938A1 (en
Inventor
Luc Lefeuvre
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Dermatologiques dUriage SAS
Original Assignee
Laboratoires Dermatologiques dUriage SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Dermatologiques dUriage SAS filed Critical Laboratoires Dermatologiques dUriage SAS
Priority to FR1770682A priority Critical patent/FR3067938B1/en
Publication of FR3067938A1 publication Critical patent/FR3067938A1/en
Application granted granted Critical
Publication of FR3067938B1 publication Critical patent/FR3067938B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/81—Preparation or application process involves irradiation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Emergency Medicine (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

L'invention concerne l'utilisation d'une composition cosmétique et/ou dermatologique pour la protection de la peau vis-à-vis des effets induits par la lumière bleue, caractérisée en ce qu'elle comprend à titre de principe actif de 0,1% à 3% en masse d'extrait de Croton Lechleri, le reste de la composition étant constituée par les ingrédients admissibles dans le domaine cosmétique et/ou dermatologique.The invention relates to the use of a cosmetic and / or dermatological composition for protecting the skin against the effects induced by blue light, characterized in that it comprises as active principle 0, 1% to 3% by mass of Croton Lechleri extract, the remainder of the composition consisting of the ingredients which are admissible in the cosmetic and / or dermatological field.

FR1770682A 2017-06-27 2017-06-27 USE OF A COSMETIC AND / OR DERMATOLOGICAL COMPOSITION AGAINST THE EFFECTS INDUCED BY BLUE LIGHT Active FR3067938B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR1770682A FR3067938B1 (en) 2017-06-27 2017-06-27 USE OF A COSMETIC AND / OR DERMATOLOGICAL COMPOSITION AGAINST THE EFFECTS INDUCED BY BLUE LIGHT

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1770682 2017-06-27
FR1770682A FR3067938B1 (en) 2017-06-27 2017-06-27 USE OF A COSMETIC AND / OR DERMATOLOGICAL COMPOSITION AGAINST THE EFFECTS INDUCED BY BLUE LIGHT

Publications (2)

Publication Number Publication Date
FR3067938A1 FR3067938A1 (en) 2018-12-28
FR3067938B1 true FR3067938B1 (en) 2020-08-28

Family

ID=60302389

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1770682A Active FR3067938B1 (en) 2017-06-27 2017-06-27 USE OF A COSMETIC AND / OR DERMATOLOGICAL COMPOSITION AGAINST THE EFFECTS INDUCED BY BLUE LIGHT

Country Status (1)

Country Link
FR (1) FR3067938B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109674720B (en) * 2019-01-24 2021-06-25 广州市瓷颜化妆品有限公司 Blue light resisting cream and preparation method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2353541B1 (en) * 2009-07-30 2011-09-20 Farmalider, S.A. COMBINATION OF COSMETIC ACTIVE INGREDIENTS AND COSMETIC COMPOSITION OBTAINED FROM THE SAME, AND ITS USE.
US20110189319A1 (en) * 2010-02-04 2011-08-04 Lorn Leitman Lifeforce liquid supplement

Also Published As

Publication number Publication date
FR3067938A1 (en) 2018-12-28

Similar Documents

Publication Publication Date Title
CO2018012181A2 (en) Amino or amino substituted aryl or heteroaryl compounds as inhibitors of ehmt1 and ehmt2
CL2019000821A1 (en) Compositions, methods and uses to inhibit arginase activity. (divisional application 201801134)
PH12016501790A1 (en) Pharmaceutical compositions of therapeutically active compounds
NI201200120A (en) DERIVATIVES OF FATTY ACID FUMARATE AND THEIR USES.
WO2014062720A3 (en) Methods of treating cancer
PH12016501788B1 (en) Pharmaceutical compositions of therapeutically active compounds
PH12015500730A1 (en) Inhibitors of histone demethylases
EA201590165A1 (en) CONTAINING ABUSE OF PHARMACEUTICAL COMPOSITIONS FOR CONTROLLED LIBERATION
EA201690753A1 (en) COMBINATION INHIBITORS OF HISTONDEACETYLASE AND IMMUNOMODULATING MEDICINES
BR112018005905A2 (en) ? compound, pharmaceutical composition, methods to prevent or treat a disease or condition, organ damage, hepatotoxicity and fatty liver, and, use of a compound?
EA201591925A1 (en) THERAPEUTIC COMPOSITIONS AND THEIR APPLICATION
EA201690039A1 (en) RORC2 INHIBITORS AND METHODS OF THEIR APPLICATION
EA201692481A1 (en) COMBINATION CONTAINING GLUCOCORTICOID AND EDO-S101
IN2014MN02056A (en)
MX2022001796A (en) Methods and compositions to inhibit symptoms associated with veisalgia.
EA202192199A1 (en) COMPOSITIONS CONTAINING CINNAMIC ACID AND METHODS OF THEIR APPLICATION
BR112015028516A2 (en) treatment or prevention of neurodegenerative disorders with the use of menthol, linalool and / or iciline
PH12016501548B1 (en) Cholesteryl ester transfer protein (cetp) inhibitor and pharmaceutical compositions comprising said inhibitor for use in the treatment or prevention of cardiovascular diseases
EA201590678A1 (en) CONNECTIONS FOR THE TREATMENT OF THE BLOCADE OF REMIELINIZATION IN DISEASES RELATED TO THE EXPRESSION OF THE PROTECTIVE PROTEIN
FR3067938B1 (en) USE OF A COSMETIC AND / OR DERMATOLOGICAL COMPOSITION AGAINST THE EFFECTS INDUCED BY BLUE LIGHT
EA201890911A1 (en) TRAZODON AND GABAPENTINE COMBINATION FOR PAIN TREATMENT
MX2018006631A (en) Compound for use in the prevention and treatment of neurodegenerative diseases.
EP3360581A4 (en) Pharmaceutical composition for preventing or treating cancer comprising inhibitor of plrg1 (pleiotropic regulator 1) as active ingredient
EP3121167A4 (en) Compound binding to pparg but not acting as promoter and pharmaceutical composition for treating pparg-related diseases containing same as active ingredient
EA202090666A1 (en) APPLICATION OF BENZOATE-CONTAINING COMPOSITION FOR TREATMENT OF GLYCINE ENCEPHALOPATHY

Legal Events

Date Code Title Description
PLSC Publication of the preliminary search report

Effective date: 20181228

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7